Pluri Inc.
NASDAQ: PLUR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yaacov Yanay
- Employees
- 106
- Headquarters
- Haifa, Israel
- IPO year
- 2003
- Market cap
- $19.1M
- Website
- https://pluri-biotech.com
Loading PLUR…
Loading profile data…Frequently asked questions about PLUR
What does Pluri Inc. (PLUR) do?
Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) ce...
Where does PLUR trade?
Pluri Inc. (PLUR) trades on the NASDAQ Global Market.
What sector is PLUR in?
Pluri Inc. (PLUR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pluri Inc.?
Yaacov Yanay is the chief executive officer of Pluri Inc. (PLUR).
Where is Pluri Inc. headquartered?
Pluri Inc. is headquartered in Israel.
Does PLUR pay a dividend?
Pluri Inc. (PLUR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PLUR go public?
Pluri Inc. (PLUR) completed its initial public offering in 2003.